Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT00006215 · UNKNOWN
Trial details
- NCT number
- NCT00006215
- Sponsor
- Amgen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.